Skip to main content
. 2017 Nov 15;7:15645. doi: 10.1038/s41598-017-15154-6

Figure 4.

Figure 4

SR141716A restores gut barrier function in diet-induced obesity. Experiments Diet-Induced Obesity (DIO) were set up as described in Fig. 1 legend. (a) Representative Periodic Acid Schiff images were used for in situ mucus layer staining, scale bar,100 μm. (b) Thickness of the mucus layer measured by histological image analysis software MetaMorph (LFD + Vehicle, n = 5; HFD + Vehicle, n = 5; SR, n = 6; PFSR, n = 5; and BWM, n = 6). (ce) mRNA expression analysis by qRT-PCR of mucus-related genes in the colonic mucosa. (f) Intestinal permeability was measured by quantitation of levels of serum FITC-Dextran (4 kDa) following oral gavage (n = 5 except LFD + Vehicle, n = 4). (g) Plasma lipopolysaccharide (LPS) level in Diet-Induced Obesity (DIO) mice treated with SR141716A for four weeks and controls was quantified (n = 5). (h) Myeloperoxidase (MPO) levels in colonic tissue were measured (n = 5). Data are shown as mean ± SD. Data with different superscript letters are significantly different (P < 0.05) according to post hoc ANOVA one-way statistical analysis.